|
1
|
Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, Wang PH, LeeHealey CJ, S. Andrews B, Sankaranarayanan A, Homerick D, Roeck WW, Tehranzadeh J, Stanhope KL, Zimin P, Havel PJ, Griffey S, Knaus HG, Nepom GT, Gutman GA, Calabresi PA, Chandy KG. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A 2006; 103:17414-9. [PMID: 17088564 PMCID: PMC1859943 DOI: 10.1073/pnas.0605136103] [Citation(s) in RCA: 424] [Impact Index Per Article: 23.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2006] [Indexed: 12/25/2022] Open
Abstract
Autoreactive memory T lymphocytes are implicated in the pathogenesis of autoimmune diseases. Here we demonstrate that disease-associated autoreactive T cells from patients with type-1 diabetes mellitus or rheumatoid arthritis (RA) are mainly CD4+ CCR7- CD45RA- effector memory T cells (T(EM) cells) with elevated Kv1.3 potassium channel expression. In contrast, T cells with other antigen specificities from these patients, or autoreactive T cells from healthy individuals and disease controls, express low levels of Kv1.3 and are predominantly naïve or central-memory (T(CM)) cells. In T(EM) cells, Kv1.3 traffics to the immunological synapse during antigen presentation where it colocalizes with Kvbeta2, SAP97, ZIP, p56(lck), and CD4. Although Kv1.3 inhibitors [ShK(L5)-amide (SL5) and PAP1] do not prevent immunological synapse formation, they suppress Ca2+-signaling, cytokine production, and proliferation of autoantigen-specific T(EM) cells at pharmacologically relevant concentrations while sparing other classes of T cells. Kv1.3 inhibitors ameliorate pristane-induced arthritis in rats and reduce the incidence of experimental autoimmune diabetes in diabetes-prone (DP-BB/W) rats. Repeated dosing with Kv1.3 inhibitors in rats has not revealed systemic toxicity. Further development of Kv1.3 blockers for autoimmune disease therapy is warranted.
Collapse
MESH Headings
- Animals
- Arthritis, Rheumatoid/drug therapy
- Arthritis, Rheumatoid/immunology
- Arthritis, Rheumatoid/metabolism
- Arthritis, Rheumatoid/pathology
- Diabetes Mellitus, Type 1/drug therapy
- Diabetes Mellitus, Type 1/immunology
- Diabetes Mellitus, Type 1/metabolism
- Diabetes Mellitus, Type 1/pathology
- Disease Models, Animal
- Electrophysiology
- Female
- Humans
- Kv1.3 Potassium Channel/antagonists & inhibitors
- Kv1.3 Potassium Channel/metabolism
- Pancreatitis-Associated Proteins
- Patch-Clamp Techniques
- Potassium Channel Blockers/pharmacology
- Rats
- Receptors, CCR7
- Receptors, Chemokine/metabolism
- T-Lymphocytes/immunology
- T-Lymphocytes/metabolism
- T-Lymphocytes/pathology
Collapse
Affiliation(s)
- Christine Beeton
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Heike Wulff
- Department of Medical Pharmacology and Toxicology, Department of Nutrition, and Comparative Pathology Laboratory, University of California, Davis, CA 95616
| | | | - Philippe Azam
- Department of Medical Pharmacology and Toxicology, Department of Nutrition, and Comparative Pathology Laboratory, University of California, Davis, CA 95616
| | | | | | - Aaron Kolski-Andreaco
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Eric Wei
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Alexandra Grino
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Debra R. Counts
- Department of Pediatrics, University of Maryland, Baltimore, MD 21201; and
| | - Ping H. Wang
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Christine J. LeeHealey
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Brian S. Andrews
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Ananthakrishnan Sankaranarayanan
- Department of Medical Pharmacology and Toxicology, Department of Nutrition, and Comparative Pathology Laboratory, University of California, Davis, CA 95616
| | - Daniel Homerick
- Department of Medical Pharmacology and Toxicology, Department of Nutrition, and Comparative Pathology Laboratory, University of California, Davis, CA 95616
| | - Werner W. Roeck
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Jamshid Tehranzadeh
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | - Kimber L. Stanhope
- Department of Medical Pharmacology and Toxicology, Department of Nutrition, and Comparative Pathology Laboratory, University of California, Davis, CA 95616
| | - Pavel Zimin
- Department of Medical Pharmacology and Toxicology, Department of Nutrition, and Comparative Pathology Laboratory, University of California, Davis, CA 95616
| | - Peter J. Havel
- Department of Medical Pharmacology and Toxicology, Department of Nutrition, and Comparative Pathology Laboratory, University of California, Davis, CA 95616
| | - Stephen Griffey
- Department of Medical Pharmacology and Toxicology, Department of Nutrition, and Comparative Pathology Laboratory, University of California, Davis, CA 95616
| | - Hans-Guenther Knaus
- **Division for Molecular and Cellular Pharmacology, Innsbruck Medical University, 6020 Innsbruck, Austria
| | - Gerald T. Nepom
- Benaroya Research Institute at Virginia Mason, Seattle, WA 98101
| | - George A. Gutman
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| | | | - K. George Chandy
- *Departments of Physiology and Biophysics, Microbiology and Molecular Genetics, Medicine, and Radiological Sciences, University of California, Irvine, CA 92697
| |
Collapse
|
|
2
|
Weiss H, Bleich A, Hedrich HJ, Kölsch B, Elsner M, Jörns A, Lenzen S, Tiedge M, Wedekind D. Genetic analysis of the LEW.1AR1-iddm rat: an animal model for spontaneous diabetes mellitus. Mamm Genome 2005; 16:432-41. [PMID: 16075370 DOI: 10.1007/s00335-004-3022-8] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2004] [Accepted: 03/08/2005] [Indexed: 11/25/2022]
Abstract
The LEW.1AR1-iddm/Ztm rat is a new animal model of type 1 diabetes mellitus, which shows an autosomal recessive mode of inheritance for the diabetes-inducing gene. The aim of this study was to define predisposing loci of the diabetic syndrome by linkage analysis using microsatellite markers. A backcross population of 218 rats (BN x LEW.1AR1-iddm) x LEW.1AR1-iddm was analyzed using 157 polymorphic microsatellite markers covering the entire genome. Three genomic regions showed a significant linkage to the diabetic syndrome. The first susceptibility locus on rat Chromosome (RNO) 1 (LOD score 4.13) mapped to the region 1q51-55, which codes for potential candidate genes like Ins1 and Nkx2-3. The second susceptibility locus was also localized on RNO1 in the centromeric region 1p11 (LOD score 2.7) encompassing the Sod2 gene. The third quantitative trait loci (LOD score 2.97) was located on RNO20 within the major histocompatibility complex region. Comparative mapping revealed that the homologous regions in the human genome contain the IDDM loci 1, 5, 8, and 17. The identification of diabetes susceptibility regions of the genetically uniform LEW.1AR1-iddm rat strain will pave the way toward a detailed characterization of the loci conferring diabetes development as well as their functional relevance for the pathogenesis of type 1 diabetes mellitus.
Collapse
Affiliation(s)
- Heike Weiss
- Institute of Clinical Biochemistry, Hannover Medical School, 30623 Hannover, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
|
3
|
Mordes JP, Guberski DL, Leif JH, Woda BA, Flanagan JF, Greiner DL, Kislauskis EH, Tirabassi RS. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 2005; 54:2727-33. [PMID: 16123363 PMCID: PMC1283095 DOI: 10.2337/diabetes.54.9.2727] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
We describe a new rat model of autoimmune diabetes that arose in a major histocompatibility complex congenic LEW rat. Spontaneous diabetes in LEW.1WR1 rats (RT1(u/u/a)) occurs with a cumulative frequency of approximately 2% at a median age of 59 days. The disease is characterized by hyperglycemia, glycosuria, ketonuria, and polyuria. Both sexes are affected, and islets of acutely diabetic rats are devoid of beta-cells, whereas alpha- and delta-cell populations are spared. The peripheral lymphoid phenotype is normal, including the fraction of ART2(+) regulatory T-cells. We tested the hypothesis that the expression of diabetes would be increased by immunological perturbation of innate or adaptive immunity. Treatment of young rats with depleting anti-ART2.1 monoclonal antibody increased the frequency of diabetes to 50%. Treatment with the toll-like receptor 3 ligand polyinosinic:polycytidylic acid increased the frequency of diabetes to 100%. All diabetic rats exhibited end-stage islets. The LEW.1WR1 rat is also susceptible to collagen-induced arthritis but is free of spontaneous thyroiditis. The LEW.1WR1 rat provides a new model for studying autoimmune diabetes and arthritis in an animal with a genetic predisposition to both disorders that can be amplified by environmental perturbation.
Collapse
Affiliation(s)
- John P Mordes
- BioMedical Research Models, 67 Millbrook St., Suite 422, Worcester, MA 01606, USA
| | | | | | | | | | | | | | | |
Collapse
|